1-hexadecyl-2-acetyl-glycero-3-phosphocholine and DDD MPGNII

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with DDD MPGNII in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alonso, J; Condom, E; Egido, J; Gómez-Chiarri, M; González, E; Lerma, JL; Ortíz, A; Seron, D	1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and DDD MPGNII

Article	Year
Fibronectin (FN) decreases glomerular lesions and synthesis of tumour necrosis factor-alpha (TNF-alpha), platelet-activating factor (PAF) and FN in proliferative glomerulonephritis. Clinical and experimental immunology, 1995, Volume: 101, Issue:2 Topics: Animals; Extracellular Matrix; Fibronectins; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative; Kidney; Leukocytes, Mononuclear; Male; Neutrophils; Platelet Activating Factor; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha	1995

Article

Year

Fibronectin (FN) decreases glomerular lesions and synthesis of tumour necrosis factor-alpha (TNF-alpha), platelet-activating factor (PAF) and FN in proliferative glomerulonephritis.

Clinical and experimental immunology, 1995, Volume: 101, Issue:2

Topics: Animals; Extracellular Matrix; Fibronectins; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative; Kidney; Leukocytes, Mononuclear; Male; Neutrophils; Platelet Activating Factor; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha

1995